Reliance Life Sciences Pvt. Ltd. - Product Pipeline Review - 2016

Published: Aug, 2016 | Pages: 35 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Summary

Global Markets Direct's, 'Reliance Life Sciences Pvt. Ltd. - Product Pipeline Review - 2016', provides an overview of the Reliance Life Sciences Pvt. Ltd.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Reliance Life Sciences Pvt. Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Reliance Life Sciences Pvt. Ltd.
- The report provides overview of Reliance Life Sciences Pvt. Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Reliance Life Sciences Pvt. Ltd.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Reliance Life Sciences Pvt. Ltd.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate Reliance Life Sciences Pvt. Ltd.'s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Reliance Life Sciences Pvt. Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Reliance Life Sciences Pvt. Ltd.'s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

 Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Reliance Life Sciences Pvt. Ltd. Snapshot 5
Reliance Life Sciences Pvt. Ltd. Overview 5
Key Information 5
Key Facts 5
Reliance Life Sciences Pvt. Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Reliance Life Sciences Pvt. Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Out-Licensed Products 10
Out-Licensed Products/Combination Treatment Modalities 11
Reliance Life Sciences Pvt. Ltd. - Pipeline Products Glance 12
Reliance Life Sciences Pvt. Ltd. - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Reliance Life Sciences Pvt. Ltd. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Reliance Life Sciences Pvt. Ltd. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
Reliance Life Sciences Pvt. Ltd. - Unknown Stage Pipeline Products 16
Unknown Products/Combination Treatment Modalities 16
Reliance Life Sciences Pvt. Ltd. - Drug Profiles 17
cetuximab biosimilar 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
darbepoetin alfa 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
pegfilgrastim 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
etanercept biosimilar 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Antisense RNAi Oligonucleotides for Undisclosed Indications 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
RSCL-0520 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
somatropin biosimilar 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Monoclonal Antibodies for Oncology and Inflammation 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
RSCL-0521 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
NeuroRel 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Reliance Life Sciences Pvt. Ltd. - Pipeline Analysis 27
Reliance Life Sciences Pvt. Ltd. - Pipeline Products by Target 27
Reliance Life Sciences Pvt. Ltd. - Pipeline Products by Route of Administration 28
Reliance Life Sciences Pvt. Ltd. - Pipeline Products by Molecule Type 29
Reliance Life Sciences Pvt. Ltd. - Pipeline Products by Mechanism of Action 30
Reliance Life Sciences Pvt. Ltd. - Dormant Projects 31
Reliance Life Sciences Pvt. Ltd. - Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Appendix 34
Methodology 34
Coverage 34
Secondary Research 34
Primary Research 34
Expert Panel Validation 34
Contact Us 34
Disclaimer 35

List of Tables

Reliance Life Sciences Pvt. Ltd., Key Information 5
Reliance Life Sciences Pvt. Ltd., Key Facts 5
Reliance Life Sciences Pvt. Ltd. - Pipeline by Indication, 2016 7
Reliance Life Sciences Pvt. Ltd. - Pipeline by Stage of Development, 2016 8
Reliance Life Sciences Pvt. Ltd. - Monotherapy Products in Pipeline, 2016 9
Reliance Life Sciences Pvt. Ltd. - Out-Licensed Products in Pipeline, 2016 10
Reliance Life Sciences Pvt. Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2016 11
Reliance Life Sciences Pvt. Ltd. - Phase III, 2016 12
Reliance Life Sciences Pvt. Ltd. - Phase II, 2016 13
Reliance Life Sciences Pvt. Ltd. - Preclinical, 2016 14
Reliance Life Sciences Pvt. Ltd. - Discovery, 2016 15
Reliance Life Sciences Pvt. Ltd. - Unknown, 2016 16
Reliance Life Sciences Pvt. Ltd. - Pipeline by Target, 2016 27
Reliance Life Sciences Pvt. Ltd. - Pipeline by Route of Administration, 2016 28
Reliance Life Sciences Pvt. Ltd. - Pipeline by Molecule Type, 2016 29
Reliance Life Sciences Pvt. Ltd. - Pipeline Products by Mechanism of Action, 2016 30
Reliance Life Sciences Pvt. Ltd. - Dormant Developmental Projects,2016 31
Reliance Life Sciences Pvt. Ltd., Other Locations 32
Reliance Life Sciences Pvt. Ltd., Subsidiaries 33